Consistent with the changes in MTS, the results from flow cytometry showed that RBBP4 knockdown combined with ropivacaine treatment induced cell cycle arrest at the G0/G1 phase in lung cancer cells, which was the most remarkable among the four groups (Fig. 4E). Here, RBBP4 is linked to lung carcinoma.